Conavi Medical Provides Shareholder Update and 2025 Outlook
January 23, 2025 07:00 ET
|
Conavi Medical Corp.
- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...
Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review
January 07, 2025 07:00 ET
|
Conavi Medical Corp.
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing,...
Conavi Medical Announces Grant of Stock Options
January 06, 2025 07:37 ET
|
Conavi Medical Corp.
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock...
Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights
December 19, 2024 07:00 ET
|
Conavi Medical Corp.
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...